Fluoroquinolone Use and Risk of Carpal Tunnel Syndrome: A Pharmacoepidemiologic Study

7Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Fluoroquinolone-induced peripheral neuropathies and tendinopathies are well documented, but there are no epidemiologic studies on the risk of carpal tunnel syndrome (CTS). We conducted a case-control study of >6 million patients. Fluoroquinolone use is associated with increased risk of CTS (rate ratio, 1.34 [95% confidence interval, 1.31-1.37]).

Cite

CITATION STYLE

APA

Cheng, J. Z., Sodhi, M., Etminan, M., & Carleton, B. C. (2017). Fluoroquinolone Use and Risk of Carpal Tunnel Syndrome: A Pharmacoepidemiologic Study. Clinical Infectious Diseases, 65(4), 684–686. https://doi.org/10.1093/cid/cix362

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free